Effect of carboxypeptidase inhibition on the in vivo and in vitro pharmacological properties of morphine and enkephalins.
D000700:Analgesics / Q000502:physiology; D000818:Animals; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors*; D004723:Endorphins / Q000494:pharmacology*; D004745:Enkephalins / Q000494:pharmacology*; D006168:Guinea Pigs; D007082:Ileum / Q000502:physiology; D008297:Male; D008715:Methionine / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D010649:Phenylalanine / Q000494:pharmacology; D010666:Phenylpropionates / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism
D000700:Analgesics; D004723:Endorphins; D004745:Enkephalins; D010666:Phenylpropionates; D010649:Phenylalanine; D009020:Morphine; D008715:Methionine; D002268:Carboxypeptidases